Of note, these authors demonstrated a sensitivity of ~50–80 % and a specificity of 100 % of methylated MGMT in serum and plasma compared to the result of MGMT analysis of the tumor tissue (Supplementary Table 3). The gene discussed is MGMT; the disease is neoplasm.